Allianz Asset Management GmbH Makes New $4.59 Million Investment in Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Allianz Asset Management acquired 536,159 Aveanna Healthcare shares worth approximately $4.59 million, while institutional investors and hedge funds collectively own 87.96% of the company.
• Analysts raised their price targets, with a consensus target of $13.50 and a “Moderate Buy” rating; targets now range as high as $15.00.
• Aveanna reported quarterly revenue of $670.48 million and EPS of $0.22, exceeding analyst estimates, but insiders sold nearly 59.9 million shares worth about $649.3 million over the past 90 days.

Allianz Asset Management GmbH bought a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 536,159 shares of the company's stock, valued at approximately $4,595,000. Allianz Asset Management GmbH owned about 0.25% of Aveanna Healthcare as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in AVAH. BlackRock Inc. bought a new position in shares of Aveanna Healthcare in the 2nd quarter worth $63,504,000. Vanguard Group Inc. increased its holdings in Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company's stock valued at $45,564,000 after purchasing an additional 1,535,351 shares during the last quarter. Braidwell LP lifted its stake in Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company's stock valued at $26,268,000 after buying an additional 861,600 shares during the period. Geode Capital Management LLC lifted its stake in Aveanna Healthcare by 17.7% in the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company's stock valued at $15,110,000 after buying an additional 278,429 shares during the period. Finally, Nuveen LLC boosted its holdings in Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company's stock worth $12,838,000 after buying an additional 905,316 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on AVAH. Barclays lifted their price objective on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an "overweight" rating in a research note on Friday, August 28th. BMO Capital Markets upped their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an "outperform" rating in a research note on Friday, August 14th. UBS Group increased their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a "neutral" rating in a report on Friday, August 14th. Truist Financial lifted their price target on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a "hold" rating in a research report on Monday, August 24th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $13.50.

Insider Buying and Selling

In other Aveanna Healthcare news, major shareholder Paul Vigano sold 14,500,002 shares of the stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the business's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 59,904,505 shares of company stock valued at $649,301,514. Company insiders own 5.30% of the company's stock.

Aveanna Healthcare Price Performance

Shares of AVAH opened at $13.66 on Wednesday. The stock has a 50 day simple moving average of $10.89 and a 200 day simple moving average of $8.40. Aveanna Healthcare Holdings Inc. has a 52-week low of $5.93 and a 52-week high of $14.00. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a market capitalization of $2.98 billion, a PE ratio of 11.11, a P/E/G ratio of 0.85 and a beta of 1.97.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million for the quarter, compared to the consensus estimate of $638.61 million. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.